Abstract-Multiple quantitative trait loci for blood pressure (BP) are localized in humans and rodent models. Model studies have not only produced human quantitative trait loci homologues but also provided unforeseen mechanistic insights into the function modality of quantitative trait loci actions. Presently, congenic knockins, gene-specific knockout, and in vitro and in vivo function studies were used in a rat model of polygenic hypertension, DSS (Dahl salt sensitive) rats. One gene previously unknown in regulating BP was detected with 1 structural mutation(s) for each of 2 quantitative trait loci classified into 2 separate epistatic modules 1 and 3. C17QTL1 in epistatic module 2 was identified to be the gene Chrm3 encoding the M3R (muscarinic cholinergic 3 receptor), since a single function-enhancing M3R T556M conversion correlated with elevated BP. To definitively prove that the enhanced M3R function is responsible for BP changes by the DSS alleles of C17QTL1, we generated a Chrm3 gene-specific rat knockout. We observed a reduction in BP without tachycardia in both sexes, regardless of the amount of dietary salt, and an improvement in diastolic and kidney dysfunctions. All occurred in spite of a significant reduction in M3R-dependent vasodilation. The previously seen sexual dimorphism for C17QTL1 on BP disappeared in the absence of M3R. A Chrm3-coding variation increased M3R signaling, correlating with higher BP. Removing the M3R signaling led to a decrease in BP and improvements in cardiac and renal malfunctions. A novel pathogenic pathway accounted for a portion of polygenic hypertension and has implications in applying new diagnostic and therapeutic uses against hypertension and diastolic dysfunction. (Hypertension. 2018;72:755-764.
D
espite extensive human association data on blood pressure (BP) [1] [2] [3] reminiscent of statistical results of model studies in the 90s, 4 their mechanism-less status and unknown functions limit our understandings of their etiologies. Challenges are to discover a gene mutation functionally causal to BP variations. The power of hypothesis-free genetics lies in discovering pathogeneses for polygenic hypertension long before their underlying physiologies are even characterized.
BP has long been thought by quantitative genetics to be built by adding up miniscule effects from multiple quantitative trait loci (QTLs). 5 Functionally, 6 when a master regulator is removed, 7 2 epistatic modules (EMs) fabricate biological blocks into the genetic architecture and constitute the 2 basic functional cores from which a multitude of QTLs act together to physiologically influence BP. 6 An EM refers to the grouping of QTLs that act epistatically to one another and affect BP in modularity as a group. The modularity mechanism framework indicates that BP as a quantitatively measured trait is not cumulatively determined and implies that the QTLs in the same EM may participate in the same pathway leading to the BP control. 8, 9 QTLs from separate EMs may act in divergent but parallel pathways. Thus, a mutated QTL product can interfere with a BP-regulating pathway without directly influencing BP by itself.
In the present work using rat models of polygenic hypertension, we aimed at systematically narrowing the chromosome interval to the smallest number of genes by fine congenic knockins 10 and identifying a candidate gene(s) for 1 QTL in 3 EMs. Finally, the causal gene for a QTL is to be proven by gene-specific knockout when it is not embryonic lethal. As September 2018 a result, 2 candidate pathways for EMs 1 and 3 were implicated. A pathogenic pathway leading to hypertension in EM 2 was identified to be mediated by the M3R (muscarinic cholinergic 3 receptor). This pathway is associated with a reduction in vasodilation and improvements in cardiac and kidney functions
Methods
The specific data that support the findings of this study are available from the corresponding author on reasonable request. Congenic, gene-targeting, phenotypings, and statistical analyses are done according to our previous publications 8, 9 and the work of others. BP was compared by repeated measures ANOVA followed by Dunnett test. For online information, please see http://hyper. ahajournals.org.
Results

Fine Congenic Knockins and Potentially Identifying Novel Pathways Regulating BP
We first functionally narrowed segments harboring 3 BP QTLs on chromosomes 2 and 17 representing each of EM1, EM2, and EM3 ( Figure 1A ). C2QTL6-, C17QTL1-, and C2QTL1-containing regions carry 3, 4, and 4 genetically different genes, respectively (Table 1; Table S1 in the online-only Data Supplement), yet this small difference alone was sufficient in biologically changing BP by each of the 3 QTLs ( Figure 1B and 1C) . In contrast to GWASs (Genome-Wide Association Studies), 1,2 every statistically significant signal associated with BP is accompanied by other genes in heterogeneity and does not prove whether the signal itself and alone can have a function impact on BP.
We next identified a specific gene potentially responsible for 1 QTL. Eif3i-ps1 in EM3 harbors variants (Table 1;  Table S2 ), is an expressed rat gene ( Figure S1 ), and is a strong genetic candidate for C2QTL1 (Figure 1 ). Among the 3 probable genes, Cd2, Igsf3, and Atp1a1, present in the C2QTL6-residing region in EM1, only Igsf3 is supported as the candidate by possessing a single nonconserved mutation (Table 1; Table S3 ; Figure S1 ). Atp1a1 cannot be genetically supported as a candidate for C2QTL6 because it contains identical codons, intron-exon junctions (Table 1) , 5′ untranslated region, including its promoter, and 3′ untranslated region (data not shown). There are no Atp1a1 copy number variations 11 and no difference in its activity comparing the DSS (Dahl salt sensitive) and MNS (Milan normotensive rats) Atp1a1 alleles.
12
Chrm3 Encoding the Cholinergic M3R Is C17QTL1
Representing EM2
Noncoding variants that originally marked C17QTL1 13 were functional artifacts because C17S.L12 ( Figure 1C ) containing them has no BP effects. The C17QTL1-residing interval harbors 4 genes ( Figure 1C ). Among them, only Chrm3 possesses a single missense mutation (Table 1 ). All 4 genes were not differentially expressed (Tables S4 and S5 ). Thus, only Chrm3 is supported as C17QTL1. The DSS strain is unique among the hypertensive and normotensive rat strains surveyed ( Figure S2 ).
Single
Chrm3
T1667C Mutation Alters M3R Activity
Since cellular functions of candidate genes, Igsf3 and Eif3i-ps1, are unknown, whereas Chrm3 is a G-protein-coupled receptor, we then focused on verifying to what extent the single Chrm3 T1667C mutation affected M3R's functions. The T556M conversion of M3R is situated in the last intracellular carboxyl terminus, suggesting a probable impact on M3R signaling and trafficking. The carbacholinduced translocation of PKC (protein kinase C) to the plasma membrane ( Figure 2A )-a downstream signaling effector of M3R-was significantly more sustained (P<0.05, t test) in the M3R-T556M mutant ( Figure 2B ) than in wildtype expressing cells. This was not because of different levels of receptor expressions (P>0.58; Figure 2C ). There was a slower (P<0.05) and less-pronounced internalization of M3R-T556M as compared with M3R ( Figure 2D) . Thus, the T556M mutation caused a delay in M3R endocytosis and resulted in increased cell surface receptors and prolonged functional signaling associated with higher BP The genes are listed in the same order as they appear on the map ( Figure 1B and 1C) . The position of a mutation enumerates from the ATG start codon. (+) and (−) indicate the nucleotide position before and after a given exon, respectively. None of the coding mutations is located on the exon side of an intron junction boundary of the gene in question. AA indicates amino acid; ATG, nucleotides; DSS, Dahl salt-sensitive rats; EM, epistatic module; MNS, Milan normotensive rats; and QTL, quantitative trait loci. ( Figure 1C ). In cells expressing AT1R (angiotensin receptor 1R; Figure 2E ), receptor internalization in response to agonist stimulation was ß arrestin dependent, whereas it was largely ß arrestin independent similarly in cells expressing M3R or M3R-T556M ( Figure 2F ). Thus, the single Chrm3 T1667C mutation alters the M3R signaling. The most crucial question to address next is: does the M3R-mediated signaling directly influence BP?
Removing M3R From DSS Rats Proves That Chrm3
Is the Causal Gene for C17QTL1
Among Igsf3, Chrm3, and Eif3i-ps1 for the 3 QTLs (Table 1) , only Chrm3 is known to be nonvital for development. We reasoned that because an enhanced M3R activity ( Figure 2 ) correlates with higher BP in DSS ( Figure 1C) , eradicating M3R from DSS should lower BP. The Lewis genome does not allow BP to fluctuate because of the presence of a hypertension suppressor, 5,7 thus it is not an appropriate background for proving the Chrm3 causation to BP.
Among 10 pups generated in the DSS background, we initially obtained 3 candidates probably in mosaic forms ( Figure 3A) , from which a Chrm3 knockout founder possesses a 5-bp deletion causing an out-of-frame shift in the Chrm3 codons ( Figure 3B and 3C) , effectively depleting it as a functional gene ( Figure 3D ). As expected from the congenic knockin, BP of Chrm3 −/− is lower than that of Chrm3 +/+ littermates in males and females, and on both high-salt and low-salt diets (Figure 4 ; Figure S3 ), without affecting heart rates.
We previously reported that knocking in the Lewis C17QTL1 alleles onto the DSS background lowered saltinduced high BP only in males but not in females. 14 In the current studies, salt-induced hypertension was more severe in wild-type Chrm3 +/+ males versus females ( Figure 4A and 4B (Figure 4) . BP was equal in both males and females in Chrm3 −/− rats under low salt. Thus, the M3R-mediated pathway has a BP-raising function that is magnified by high salt in both sexes. A lack of this function cannot be compensated by any remaining 4 types of M receptors 15 or any other genes. Paradoxically, Chrm3 −/− rats showed a reduced vasodilatory response to acetylcholine in freshly isolated cerebral and mesentery vessels as compared with Chrm3 +/+ littermates ( Figure S4 ).
Eliminating M3R From DSS Rats Improves Diastolic Dysfunction and LV Hypertrophy
Because DSS C17QTL1 alleles ( Figure 1C ) also cause diastolic dysfunction in males on a high-salt diet with preserved ejection fraction 16 and Chrm3 is C17QTL1 in the above work, we reasoned that Chrm3 nulls from DSS rats should have a beneficial impact on diastolic function. Indeed, diastolic dysfunction is improved in Chrm3 −/− rats compared with Chrm3 +/+ most noticeably in males (Tables 2 and 3) , as is the case for LV hypertrophy (Table 4) . Removing M3R even improved systolic function in males (Table 5) , whereas a heightened activity of M3R exhibited by DSS C17QTL1 alleles had no effect. 16 These data show that M3R mediates a pleiotropic pathway that enhances diastolic dysfunction and LV hypertrophy and negatively 
Discussion
Major findings from this work are (1) protein-changing mutations in genes are candidates for 3 QTLs in 3 separate EMs/ pathways. They act as polygenic drivers toward the BP homeostasis. (2) Igsf3 and Eif3i-ps1 are genetic candidates for C2QTL6 in EM1 and C2QTL1 in EM3, respectively, and were not previously known to be involved in BP modulations either directly or indirectly. (3) Chrm3 is the causal gene for C17QTL1 in EM2 and establishes a novel BP-raising pathway mediated by M3R, in spite of vasodilation capacity and in spite of 1096 Chrm3 noncoding variants with unknown functions. 9, 11 (4) Mechanistically in the context of quantitative traits, Chrm3 has new pleiotropic functions on BP, cardiac functions, and LV hypertrophy, beyond previously known effects. 17 (5) A molecular mechanism of the M3R-mediated signaling to hypertension is associated with an improvement in renal function.
M3R-Mediated Signaling Is a Novel Mechanistic Pathway of BP Determination in EM 2
Biologically mechanistic insights driven by functions have (1) provided the molecular support for the concept of modularity, 6 (2) laid a new conceptual foundation for mechanistic and biological understandings of QTL functions in the framework of pathways, 8 and (3) revealed a previously unsuspected pathogenesis as a part of polygenicity contributing to the BP homeostasis. M3R was not known as a direct BP-determining agent, yet removing it proves that Chrm3 is the causal gene for C17QTL1.
The results molecularly prove in principle that a pathway mechanistically accounting for a hypertension pathogenesis biologically underlines the basic function of an EM ( Figure 1A ). M3R serves as an entry point for completing the pathway with other QTLs as building blocks in EM2.
Although a noncoding Chrm3 variant 9,11 might affect its expression, the pivotal mechanistic determinant of C17QTL1/Chrm3 on BP relies solely on the M3R function. Because 1 copy of a functional Chrm3 in Chrm3 +/− is dominant ( Figure 4A) , it is the qualitative presence of the functional M3R itself that ensures the integrity of the pathway. A function, if any, of the noncoding single nucleotide polymorphism 1 marking the human hypertension QTL is inconsequential to the M3R function, albeit the single nucleotide polymorphism and its surrounding area near Chrm3 cannot be targeted for knockout because of a lack of rat-human sequence conservations.
Functional Dose of M3R Signaling Determining a Sexual Dimorphism
In the absence of M3R, an effect on sexual dimorphism of C17QTL1 previously observed by congenic knockin genetics 14 was eliminated, indicating that the M3R-mediated pathway plays an important role in the pathogenesis of hypertension in both males and females. It is noteworthy that M3R controls BP in a sexual dimorphism with male specificity or in both sexes, all depending on a varying functional dose in M3R signaling. A decrease in BP is limited to males 14 when the functional dose in the M3R signaling diminishes. An enhanced reduction in BP extends to both males and females, when the functional dose of M3R signaling is eliminated. In this case, the absolute amount of the M3R protein is not a determining factor because heterozygous Chrm3 −/+ rats have 1 copy of Chrm3 and yet have the same BP as Chrm3 +/+ rats that have 2 copies of Chrm3 ( Figure 4A ).
M3R Signaling Elevates BP in Both Sexes Regardless of the Amount of Dietary Salt
DSS rats have been known as a salt-sensitive model of hypertension, yet eliminating M3R reduced BP of males and females also on low salt ( Figure 4E ), even though the BP magnitude was different (P<0.012) between Chrm3 −/− rats on high-salt (ie, 111±2 mm Hg) versus on low-salt diet (104±2 mm Hg). Thus, the hypertension pathogenesis mediated by M3R signaling is widely applicable independent of the dietary salt concentration and seems potentially translatable to the general human populations 2,3 irrespective of salt sensitivity.
Chrm3-Coding Mutations as BP-Susceptible Targets
Structural mutations would assume to be unique to genes of monogenic hypertension, 18 whereas varying degrees of gene expressions in multiple QTLs would underlie polygenic hypertension. 19 In a polygenic and quantitative context, a thorough screening of CHRM3-coding mutations seems warranted among hypertensives in worldwide human populations. Coding CHRM3 mutations may not be limited to 1 single-point mutation in general human populations. No polygenic etiologies mechanistically justify that all hypertensives should carry the same Chrm3 T1667 missense mutation. Spontaneously hypertensive rats lack the Chrm3 T1667 mutation ( Figure S2B ), despite hypertension. Modularity 6, 8 can biologically explain this outcome because multi-QTLs in EM1 and EM2 in different hypertensive individuals can functionally affect different steps in the same pathway ( Figure 1A) , or even in different pathways, and consequently, all reach a similar hypertensive state.
M3R-Mediated Pathway in Diastolic Function
Factors regulating diastolic function 20 now include the M3R-mediated signaling. To date, no case is known of a QTL altering only diastolic function without affecting BP, 21 which the Chrm3-specific knockout reinforces and implicates a common pathway for both ( Figure 4 ; Tables 2 through 5). It is also possible that the improvement on diastolic dysfunction could be secondary to reducing BP, although lowering BP per se by certain QTL alleles (eg, by Lewis C16QTL alleles) did not improve diastolic dysfunction. 22 Treatments 20 for heart failure with preserved ejection fraction are limited. Thus, understanding and targeting their etiologic mechanisms, including the M3R-mediated signaling, may be valuable in discovering effective anti-heart failure with preserved ejection fraction therapies.
Molecular Mechanisms Mediated by M3R in BP Regulation
Paradoxically, vasodilation ( Figure S4) CF-1 derivative. 23 In spite of it, our congenic knockin genetics indicated 16 that elevating M3R activities ( Figure 2 ) should cause hypertension ( Figure 1C) , not hypotension. The followup data on DSS-based Chrm3 nulls have verified this causal pathogenesis (Figure 4) . Thus, the hypertension pathophysiology driven by M3R does not seem vasculature centered, indicating that our previous hypothesis of the hypertension pathogenesis was incomplete. Thus, an alternative mechanism originating from M3R is in order. The endothelial M3R is known to induce vasodilation, but the endogenous agonist, acetylcholine, has never been shown to be a major mediator in plasma in vivo. Acetylcholine is released in the perivascular space by nerve termini, and it is extremely labile with a halflife of seconds in tissues and plasma. So the M3R-mediated signaling without the natural agonist may not be an obligatory pathway for BP regulation in vasculature.
In the congenic C17S.L11 rats, only the M3R is functionally different from that of the DSS rats, whereas the remaining 4 types of M receptors are genomically identical. The differing DSS M3R in structure is most likely responsible for the increase in BP. The level of Chrm3 expression is not different between DSS and the congenic C17S.L11 rats (Table S4) .
M3R-Mediated Pathway in Renal Function
There is a significant difference in mean arterial pressure (P<0.012) between male Chrm3 −/− rats on high-salt (ie, 111±2 mm Hg) versus on low-salt diet (104±2 mm Hg; Figure 4) . Because kidneys are known to play an important role in the pressure natriuresis and diuresis, 24 kidney functions are predicted to be affected by M3R. Indeed, the renal excretory function was ameliorated on a high-salt diet in both males and females when M3R is eliminated from DSS. Although our current studies cannot establish a direct cause-effect relationship 1 way or the other between BP and kidney functions mediated by M3R, there is a clear dissociation in pathogenic mechanisms between BP and vasodilation ( Figure S4 ), which future studies will address.
Specific Candidate Gene Functions Implicate Separate Mechanistic Pathways for 2 BP QTLs in EM1 and EM3
Unlike Chrm3, Igsf3 is indispensable for embryonic development ( Figure 1B) . 25 Because Igsf3 contains a coding mutation (Table 1) , a permanent structural or possibly functional change in the pathway that it affects might start in embryos and continues to into adulthood. An adverse fetal insult in utero 26 is known to lead to long-lasting physiological and structural modifications in nephrogenesis and vascular formation during prenatal development, which can have far-reaching consequences in the adult BP physiology. Little is known about the mechanism by which Eif3i-ps1/C2QTL1 functions ( Figure 1B) as a sole representative of EM3 in the BP control. 6 In conclusion, we have functionally reduced the polygenic complexity to their individual monogenic architectures under a uniform environment. Congenic knockin genetics has proven biologically that BP as a quantitative trait is qualitatively determined by EMs 6 and, based on it, has identified a novel signaling pathway of pathogenesis for hypertension and diastolic dysfunction. The Chrm3 knockout has validated this outcome. The present study observed associations between a BP reduction and improvements in the renal and cardiac functions, without establishing a cause-effect relationship one way or the other. An uncoupling between a BP reduction and vasodilation is evident. Establishing a prohypertensive pathway triggered by M3R entails comprehensive understandings of other mechanisms in the future studies. Chrm3 KO provides a molecular evidence for a pathway as the underlying mechanism for EM 2/noncumulativity for QTLs in determining BP.
Perspectives
M3R as a cause-based therapy target causal to hypertension can help with the genetics-to-drug therapy discovery. 27 To put it in perspective, the current BP genetic research by GWASs in humans 1,2 faces great challenges even in identifying the functional variants determining BP variations. Large gaps have to be filled before a therapy is possible. Our results represent model studies that reveal disease etiologies, drive, and potentially produce nonexistent yet highly desirable human diagnostic and treatment innovations in a multifactorial, quantitative, and polygenic framework. 
Sources of Funding
Disclosures
None.
